Key facts
- This page summarizes John E. Bishop's Form 4 filing for Lyra Therapeutics, Inc. (LYRA).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 01 Feb 2024, 16:15.
John E. Bishop - 30 Jan 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)
- Signature
- /s/ Jason Cavalier, Attorney-in-Fact
- Issuer symbol
- LYRA
- Transactions as of
- 30 Jan 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 01 Feb 2024, 16:15:20 UTC
- Previous filing
- 28 Feb 2023
- Next filing
- 17 Oct 2025
- SEC
- View on sec.gov
Key filing fact
John E. Bishop filed Form 4 for Lyra Therapeutics, Inc. (LYRA) on 01 Feb 2024.
Change
- Previous filing in this sequence was filed on 28 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
LYRA
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +200,000
- Change %
- Price
- $0.000000
- Shares after
- 200,000
- Date
- 30 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200,000
- Exercise price
- $4.58
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 30, 2024. |